| NAME | : | Enzalutamide |
| BOBOT | : | 464.436 |
| RUMUS | : | C21H16F4N4O2S |
| THERAPEUTIC INDC | : | Enzalutamide is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. |
| CATEGORIES | : | Androgen Antagonists |
| STRUCTURE | : |  |